Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
Sales | 15,995,000 | 17,132,000 | 16,576,000 | 15,797,000 | 11,621,000 |
Cost of Goods | 3,790,000 | 3,684,000 | 4,202,000 | 3,506,000 | 1,789,000 |
Gross Profit | 12,205,000 | 13,448,000 | 12,374,000 | 12,291,000 | 9,832,000 |
Operating Expenses | 8,442,000 | 9,247,000 | 8,813,000 | 12,330,000 | 5,701,000 |
Operating Income | 3,763,000 | 4,201,000 | 3,561,000 | -39,000 | 4,131,000 |
Other Income | -2,349,000 | -275,000 | -412,000 | -110,000 | -160,000 |
Pre-tax Income | 1,414,000 | 3,926,000 | 3,149,000 | -149,000 | 3,971,000 |
Income Tax | 558,000 | 1,472,000 | 1,135,000 | -807,000 | 1,092,000 |
Net Income Continuous | 856,000 | 2,454,000 | 2,014,000 | 658,000 | 2,879,000 |
Net Income Discontinuous | 15,000 | 31,000 | 21,000 | 108,000 | 2,000 |
Minority Interests | 5,000 | 10,000 | 9,000 | -1,000 | 3,000 |
Net Income | $866,000 | $2,475,000 | $2,026,000 | $767,000 | $2,878,000 |
EPS Basic Total Ops | 0.11 | 0.31 | 0.25 | 0.05 | 0.43 |
EPS Basic Continuous Ops | 0.11 | 0.31 | 0.25 | 0.04 | 0.43 |
EPS Basic Discontinuous Ops | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
EPS Diluted Total Ops | 0.11 | 0.31 | 0.25 | 0.06 | 0.43 |
EPS Diluted Continuous Ops | 0.11 | 0.30 | 0.25 | 0.04 | 0.43 |
EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
EBITDA(a) | $5,992,000 | $6,414,000 | $5,612,000 | $1,735,000 | $5,100,000 |